Search results
Found 90 matches for
The Oxford Epilepsy Research Group is at the forefront of some potentially ground-breaking work with patients who have drug-resistant epilepsy. Epilepsy affects over 50 million people worldwide and nearly one in three people with epilepsy are resistant to current drugs.
Welcome Prof Shelley McKeown Jones
Research Highlights Strategic Developments
26 January 2024
Fellow and Tutor in Experimental Psychology with Lady Margaret Hall joining us from Bristol
Farewell to the Le Gros Clark Building
Strategic Developments
29 November 2023
We say goodbye to a building that has been central through our development as DPAG
Launch of innovative new study to tackle mental health inequalities
Research Highlights Strategic Developments
29 November 2023
An innovative new study working with diverse people living with psychosis and other long-term physical health conditions.
Brain Health Innovation Summit
Events Strategic Developments
28 November 2023
Where expertise meets innovation:a taskforce driving brain health research
Professor David M Clark joins Oxford Health as Non-Executive Director
Awards and Honours Strategic Developments
20 July 2023
The Emeritus Professor of Experimental Psychology took up his role on 17 July 2023.
University of Oxford and Selvita collaborate to advance potential therapeutics for Parkinson's Disease
Strategic Developments
1 June 2023
The University of Oxford and Selvita (WSE: SLV), one of the largest contract research organisations in Europe, are collaborating on drug discovery in the area of Parkinson's disease
Brain and mental health innovation at Oxford
Research Highlights Strategic Developments
22 May 2023
Mental Health and Dementia are a global healthcare crisis, affecting over one billion people worldwide. Of those, over 400 million people are on the Alzheimer's disease continuum, with one person diagnosed every three seconds, and the figure expected to rise as the global population of those over 60 is set to double by 2050.
Experts hold first meeting for new international project on depression, anxiety and psychosis
Strategic Developments
23 March 2023
The Global Alliance for Living Evidence on aNxiety, depressiOn and pSychosis, or GALENOS project, has launched in central London.
Ensuring LGBTQI+ people are treated fairly in mental health data
Research Highlights Strategic Developments
28 February 2023
Andrey Kormilitzin outlines a new participatory study aimed at improving AI to take account of LGBTQI+ people so that their needs are better met by mental health services.
Steve Kennerley joins EP as Professor of Cognitive and Systems Neuroscience
Research Highlights Strategic Developments
27 February 2023
Life and Mind Building construction tops out
Events Strategic Developments
16 February 2023
Another milestone was reached this week with the topping out ceremony of the new Life and Mind Building.
Oxford spinout trials revolutionary bioelectronic implant to treat incontinence
Research Highlights Strategic Developments
3 February 2023
The first participants in a clinical trial of a bioelectrical therapy to treat incontinence have received their “smart” bioelectronic implants.
Director of MRC Brain Network Dynamics Unit appointed
Strategic Developments
15 December 2022
From 2 January 2023, Professor Peter Magill will lead the Medical Research Council Brain Network Dynamics Unit (MRC BNDU) at the University of Oxford.
Oxford gets £122m funding for healthcare research
Strategic Developments
14 October 2022
Health and care research in Oxford is to receive £122 million in government funding over the next five years to improve diagnosis, treatment and care for NHS patients.
IDRM officially opens in Oxford
Strategic Developments
20 July 2022
A celebration for the opening of the Institute of Developmental & Regenerative Medicine (IDRM) led by Paul Riley took place on Tuesday 12 July 2022, attended by many DPAG members who have recently relocated to this fantastic new Institute.
European Magnetic Resonance Imaging in MS Group celebrates 20 years
Research Highlights Strategic Developments
25 May 2022
NICE recommends offering app-based treatment for people with insomnia instead of sleeping pills
Research Highlights Strategic Developments
24 May 2022
Hundreds of thousands of people suffering from insomnia who would usually be prescribed sleeping pills could be offered an app-based treatment programme instead, NICE has said.
Developmental dynamics of the neural crest–mesenchymal axis in creating the thymic microenvironment
Research Highlights Strategic Developments
16 May 2022
A new paper from researchers at the Department of Paediatrics and the Nuffield Department of Clinical Neurosciences has shown that fibroblasts in the thymus, often considered simply as dull “structural” cells, are much more complex than previously thought.
Unique study of vascular disease reaches 20th anniversary
Research Highlights Strategic Developments
19 April 2022
The only project of its kind anywhere that studies patients with all types of acute vascular events - including strokes, heart attacks, aneurysms - in order to develop better diagnostic tests and treatments celebrates its 20th anniversary this month.